Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer
Background/Objectives: Breast cancer, a leading health threat affecting millions worldwide, requires effective therapeutic interventions. Celastrol (CEL), despite its antitumor potential, is limited by poor solubility and stability. This study aimed to enhance CEL’s efficacy by encapsulating it with...
Saved in:
| Main Authors: | Wei Zhang, Jiping Li, Liling Yue, Chenfeng Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/11/1382 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer
by: Wei Zhang, et al.
Published: (2025-05-01) -
Bacteria-Assisted Celastrol Liposomes for Effective Chemotherapy Against Lung Cancer in Mice Model
by: Wang X, et al.
Published: (2025-04-01) -
Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models
by: Siukan Law, et al.
Published: (2020-01-01) -
Synergistic effect of pH-sensitive PEGylated RG3-chitosan prodrug nanoparticles encapsulated celastrol on pancreatic cancer
by: Zheng Zhang, et al.
Published: (2025-12-01) -
Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway
by: Biqiang Zhu, et al.
Published: (2020-01-01)